CVS Health Corp (CVS) Expected to Announce Quarterly Sales of $47.58 Billion

Analysts forecast that CVS Health Corp (NYSE:CVS) will report sales of $47.58 billion for the current fiscal quarter, according to Zacks. Eighteen analysts have issued estimates for CVS Health’s earnings. The lowest sales estimate is $46.84 billion and the highest is $48.26 billion. CVS Health reported sales of $45.97 billion in the same quarter last year, which indicates a positive year over year growth rate of 3.5%. The company is scheduled to announce its next quarterly earnings report on Thursday, February 8th.

On average, analysts expect that CVS Health will report full-year sales of $47.58 billion for the current financial year, with estimates ranging from $183.22 billion to $184.55 billion. For the next fiscal year, analysts expect that the company will report sales of $188.34 billion per share, with estimates ranging from $186.91 billion to $192.26 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that that provide coverage for CVS Health.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.64 EPS.

A number of equities analysts recently weighed in on CVS shares. Oppenheimer reissued a “buy” rating and issued a $95.00 price target on shares of CVS Health in a report on Monday, October 9th. Needham & Company LLC restated a “hold” rating on shares of CVS Health in a research note on Thursday, October 12th. SunTrust Banks set a $85.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Thursday, October 12th. Jefferies Group set a $86.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Wednesday, October 18th. Finally, Mizuho set a $90.00 price target on CVS Health and gave the company a “buy” rating in a research report on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $87.25.

In related news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the transaction, the executive vice president now owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.61% of the stock is owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in the stock. Pathstone Family Office LLC lifted its holdings in shares of CVS Health by 341.0% in the 2nd quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock worth $2,353,000 after buying an additional 982 shares during the period. Wealthcare Advisory Partners LLC raised its position in shares of CVS Health by 330.3% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares in the last quarter. Fieldpoint Private Securities LLC raised its position in shares of CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI raised its position in shares of CVS Health by 119.6% in the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares in the last quarter. Finally, MPS Loria Financial Planners LLC acquired a new position in CVS Health during the 2nd quarter valued at about $119,000. 81.69% of the stock is currently owned by institutional investors.

CVS Health (CVS) traded up $0.05 on Friday, reaching $79.40. 2,854,244 shares of the company’s stock were exchanged, compared to its average volume of 8,784,892. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The stock has a market cap of $80,420.00, a P/E ratio of 16.40, a price-to-earnings-growth ratio of 1.25 and a beta of 0.90. CVS Health has a 1 year low of $66.45 and a 1 year high of $84.00.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. CVS Health’s dividend payout ratio is presently 41.32%.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2018/01/19/cvs-health-corp-cvs-expected-to-announce-quarterly-sales-of-47-58-billion.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Get a free copy of the Zacks research report on CVS Health (CVS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply